Sponsor Pipeline

Affiliated Cancer Hospital & Institute of Guangzhou Medical University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
12
Active Trials
4
Recruiting
2
Phase 3
6
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
7
Early Phase 1
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04437329 Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma Recruiting
NCT06327932 HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer Non-Muscle-Invasive Bladder Cancer Not Yet Recruiting
Phase 2
NCT07286240 QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian… Treatment of Recurrent Ovarian Cancer Recruiting
NCT07286253 QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A… Neoadjuvant Treatment for Locally Advanced Cervical Cancer Recruiting
NCT05484375 Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma… Metastatic Nasopharyngeal Carcinoma Not Yet Recruiting
NCT05484583 Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in… Lung Cancer Not Yet Recruiting
NCT05648487 HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis Gastric Cancer Not Yet Recruiting
NCT06594172 Early Application of Memantine and Pioglitazone to Protect Cognitive Function After… Radiation Disease Not Yet Recruiting
NCT04922658 Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer Advanced Non-Small Cell Lung Cancer Active, Not Recruiting
Early Phase 1
NCT06570538 Analgesic Efficacy of an Opioid-free Postoperative Pain Management Strategy Versus a… Postoperative Pain Not Yet Recruiting
Not specified
NCT07602569 A Prospective Study on the Diagnosis of Malignant Tumors With 18F-FGIn PET/CT Cancer (With or Without Metastasis) Recruiting
NCT05661110 Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With… Gastric Cancer Not Yet Recruiting
Disease Areas
Get alerts when Affiliated Cancer Hospital & Institute of Guangzhou Medical University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free